Amir Pelleg
Corporate Officer/Principal at Drexel University
Profile
Amir Pelleg has been President and Chief Scientific Officer of Duska Therapeutics, Inc. since August 2004.
Previously, he was a Director and Chairman of Duska Therapeutics from 2004 to 2007.
Dr. Pelleg has been President, Chief Scientific Officer and a Director of Duska Scientific since 1996 and Chief Operating Officer since January 2004.
He was a Member of Duska Scientific's Executive Committee.
Dr. Pelleg was a Professor of Medicine and Pharmacology at Drexel University College of Medicine, Philadelphia, Pennsylvania from 1992 to 2004.
He is an Adjunct Professor at Drexel University College of Medicine.
Dr. Pelleg has experience in the physiology and pharmacology of ATP.
He is a Member of the Editorial Board of The American Journal of Therapeutics.
Dr. Pelleg received a BS degree in Biology from Tel-Aviv University, an MS in Bioengineering from the Polytechnic Institute of Brooklyn and a PhD in Human Physiology from Louisiana State University.
Amir Pelleg active positions
| Companies | Position | Start |
|---|---|---|
| Drexel University | Corporate Officer/Principal | 1991-12-31 |
Former positions of Amir Pelleg
| Companies | Position | End |
|---|---|---|
Duska Scientific Co.
 Duska Scientific Co. Pharmaceuticals: MajorHealth Technology Part of Cordex Pharma, Inc., Duska Scientific Co. is a company that manufactures biopharmaceutical products. The company is based in Haverford, PA. | President | - |
Cordex Pharma, Inc.
 Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | President | - |
Training of Amir Pelleg
| Tel-Aviv University | Undergraduate Degree |
| Louisiana State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Cordex Pharma, Inc.
Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Health Technology |
Duska Scientific Co.
Duska Scientific Co. Pharmaceuticals: MajorHealth Technology Part of Cordex Pharma, Inc., Duska Scientific Co. is a company that manufactures biopharmaceutical products. The company is based in Haverford, PA. | Health Technology |
| Polytechnic University | Consumer Services |
- Stock Market
- Insiders
- Amir Pelleg
